Monday, November 18, 2024
HomeTagsDeficient mismatch repair

deficient mismatch repair

Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer

Agenus Inc., a leader in discovering and developing novel immunological agents to treat various cancers, announced updated results from its Phase 1 clinical trial...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics